GSK, iTeos plan cancer drug development - News - Dukascopy Bank
Mon, 14 Jun 2021 18:00:07 GMT
Source: Dukascopy Bank SA
Britain's GlaxoSmithKline is set to pay $2.0B to iTeos Therapeutics for the development and further sale of potential cancer treatment in a tie-up, both the companies announced on Monday.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.
To learn more about Dukascopy Bank Binary Options
/ Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Dukascopy Bank CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Business Introducer and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.